The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones

Carrie R. Sowers, Rong Wang, Rebecca A. Bourne, Barbara Claire McGrath, Jingjie Hu, Sarah C. Bevilacqua, James C. Paton, Adrienne W. Paton, Sophie Collardeau-Frachon, Marc Nicolino, Douglas R. Cavener

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.

Original languageEnglish (US)
Pages (from-to)5134-5149
Number of pages16
JournalJournal of Biological Chemistry
Volume293
Issue number14
DOIs
StatePublished - Jan 1 2018

Fingerprint

Proinsulin
Endoplasmic Reticulum
Protein Kinases
Processing
Proteins
Agglomeration
Insulin
Phenotype
Unfolded Protein Response
Fractionation
Medical problems
Imaging techniques
Defects
Mutation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Sowers, Carrie R. ; Wang, Rong ; Bourne, Rebecca A. ; McGrath, Barbara Claire ; Hu, Jingjie ; Bevilacqua, Sarah C. ; Paton, James C. ; Paton, Adrienne W. ; Collardeau-Frachon, Sophie ; Nicolino, Marc ; Cavener, Douglas R. / The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones. In: Journal of Biological Chemistry. 2018 ; Vol. 293, No. 14. pp. 5134-5149.
@article{7084f9a39e8346da93bce05e8789a5e8,
title = "The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones",
abstract = "Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.",
author = "Sowers, {Carrie R.} and Rong Wang and Bourne, {Rebecca A.} and McGrath, {Barbara Claire} and Jingjie Hu and Bevilacqua, {Sarah C.} and Paton, {James C.} and Paton, {Adrienne W.} and Sophie Collardeau-Frachon and Marc Nicolino and Cavener, {Douglas R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1074/jbc.M117.813790",
language = "English (US)",
volume = "293",
pages = "5134--5149",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "14",

}

The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones. / Sowers, Carrie R.; Wang, Rong; Bourne, Rebecca A.; McGrath, Barbara Claire; Hu, Jingjie; Bevilacqua, Sarah C.; Paton, James C.; Paton, Adrienne W.; Collardeau-Frachon, Sophie; Nicolino, Marc; Cavener, Douglas R.

In: Journal of Biological Chemistry, Vol. 293, No. 14, 01.01.2018, p. 5134-5149.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones

AU - Sowers, Carrie R.

AU - Wang, Rong

AU - Bourne, Rebecca A.

AU - McGrath, Barbara Claire

AU - Hu, Jingjie

AU - Bevilacqua, Sarah C.

AU - Paton, James C.

AU - Paton, Adrienne W.

AU - Collardeau-Frachon, Sophie

AU - Nicolino, Marc

AU - Cavener, Douglas R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.

AB - Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.

UR - http://www.scopus.com/inward/record.url?scp=85045062292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045062292&partnerID=8YFLogxK

U2 - 10.1074/jbc.M117.813790

DO - 10.1074/jbc.M117.813790

M3 - Article

C2 - 29444822

AN - SCOPUS:85045062292

VL - 293

SP - 5134

EP - 5149

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 14

ER -